![]() |
Breast Cancer |
Free Subscription
1 AJR Am J Roentgenol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Breast Cancer is free of charge.
The Natural History of Screen-Detected Prostate and Breast Cancer.
AJR Am J Roentgenol. 2025 May 28. doi: 10.2214/AJR.25.33170.
PubMed
Interobserver agreement in scoring HER2-negative and HER2-low
immunohistochemistry in breast cancer: Reasons for discordance and impact of a
single training session.
Am J Clin Pathol. 2025 May 23:aqaf043. doi: 10.1093.
PubMed
Abstract available
Letter to the editor 'A pooled analysis of trastuzumab deruxtecan in patients
with human epidermal growth factor receptor 2 (HER2)-positive metastatic breast
cancer with brain metastases' by F. Andre et al.
Ann Oncol. 2025 May 21:S0923-7534(25)00735-5. doi: 10.1016/j.annonc.2025.
PubMed
Phase II Study of the Effectiveness of the Germinated Wheat-derived Rigenase Plus
Polyhexanide in the Prophylaxis for Hypofractionated Radiation-induced Acute Skin
Toxicity in Breast Cancer.
Anticancer Res. 2025;45:2539-2550.
PubMed
Abstract available
Combined Biomarkers for Prediction of Immune Checkpoint Inhibitor Response in
Patients With Triple-negative Breast Cancer.
Anticancer Res. 2025;45:2575-2586.
PubMed
Abstract available
Intratumoral Injection of Allogeneic NK Cell With Chemotherapy in a
Triple-negative Breast Cancer Preclinical Model.
Anticancer Res. 2025;45:2669-2688.
PubMed
Abstract available
The Role of EMP2 in Triple-negative Breast Cancer.
Anticancer Res. 2025;45:2417-2427.
PubMed
Abstract available
Feasibility of an Exercise Training Program Among Patients With Newly Diagnosed
Advanced Breast Cancer.
Anticancer Res. 2025;45:2605-2618.
PubMed
Abstract available
Evaluating the breast cancer quality of care indicators in Iran; multicenter
study.
BMC Cancer. 2025;25:925.
PubMed
Abstract available
Clinical prediction of pathological complete response in breast cancer: a machine
learning study.
BMC Cancer. 2025;25:933.
PubMed
Abstract available
Prediction of one-year recurrence among breast cancer patients undergone surgery
using artificial intelligence-based algorithms: a retrospective study on
prognostic factors.
BMC Cancer. 2025;25:940.
PubMed
Abstract available
Barriers and opportunities related to access to oncology care in Benin: a
qualitative study on breast cancer.
BMC Cancer. 2025;25:947.
PubMed
Abstract available
Safety and quality of life of CDK4/6 inhibitors therapy for hormone
receptor-positive, human epidermal growth factor receptor 2-negative advanced
breast cancer: a multicenter cross-sectional survey in China.
BMC Cancer. 2025;25:951.
PubMed
Abstract available
Ki-67-Playing a key role in breast cancer but difficult to apply precisely in the
real world.
BMC Cancer. 2025;25:962.
PubMed
Abstract available
Optimal patient population for adjuvant S-1 therapy in hormone receptor-positive,
HER2-negative early breast cancer.
Breast Cancer. 2025 May 24. doi: 10.1007/s12282-025-01722.
PubMed
Abstract available
Helix pomatia agglutinin bound to surface glycans of small extracellular vesicles
in-vitro and in-vivo increases in early and late stage breast cancer.
Breast Cancer. 2025 May 24. doi: 10.1007/s12282-025-01724.
PubMed
Abstract available
Axillary surgery in patients with breast cancer with one to three positive micro-
or macrometastases in the sentinel lymph nodes: an observational study.
Breast Cancer. 2025 May 25. doi: 10.1007/s12282-025-01726.
PubMed
Abstract available
Immediate breast reconstruction surgery for breast cancer: current status and
future directions.
Breast Cancer. 2025 May 26. doi: 10.1007/s12282-025-01723.
PubMed
Abstract available
Real-World Experience of HER2-Positive Advanced Breast Cancer (ABC) Treatment and
Evaluation of Blood Biomarkers in a Public Institution in Latin America (LATAM).
Breast Cancer (Auckl). 2025;19:11782234251342477.
PubMed
Abstract available
Breast Cancer (Dove Med Press)
Barriers to Early Breast Cancer Diagnosis in Sudanese Women Before the War.
Breast Cancer (Dove Med Press). 2025;17:433-445.
PubMed
Abstract available
Advances in Targeted Therapy for Brain Metastases in Human Epidermal Growth
Factor Receptor 2 (HER2)-Positive Breast Cancer: A Focus on ADCs and TKIs.
Breast Cancer (Dove Med Press). 2025;17:423-432.
PubMed
Abstract available
Identification of vitronectin as a potential non-invasive biomarker of metastatic
breast cancer using a label-free LC-MS/MS approach.
Breast Cancer Res. 2025;27:94.
PubMed
Abstract available
Investigating the mechanism of inositol against paclitaxel chemoresistance on
triple-negative breast cancer by using 7T multiparametric MRI and mitochondrial
changes.
Breast Cancer Res. 2025;27:93.
PubMed
Abstract available
NOTCH1 inhibition enhances immunogenicity and sensitizes triple-negative breast
cancer to immune checkpoint inhibitors.
Breast Cancer Res. 2025;27:92.
PubMed
Abstract available
Subtype-specific dysregulation of biogenic amine-related genes and miRNAs in
breast cancer: identification of DRD2, HRH2, and HRH4 as potential therapeutic
targets in TNBC and HER2+ subtypes.
Breast Cancer Res Treat. 2025 May 27. doi: 10.1007/s10549-025-07732.
PubMed
Abstract available
Exploring the Nottingham classification: assessing gene expression profiles in
breast cancer patients and their association with outcomes.
Breast Cancer Res Treat. 2025 May 28. doi: 10.1007/s10549-025-07718.
PubMed
Abstract available
Breast magnetic resonance imaging patterns of tumor regression after neoadjuvant
chemotherapy and immunotherapy in early triple-negative breast cancer patients:
prediction of pathological response and performance of ultrafast sequences.
Breast Cancer Res Treat. 2025 May 28. doi: 10.1007/s10549-025-07650.
PubMed
Abstract available
Metastatic breast cancer through the Oncotype DX Breast Recurrence Score(R):
insights from a small cohort study.
Breast Cancer Res Treat. 2025 May 28. doi: 10.1007/s10549-025-07736.
PubMed
Abstract available
Genomic and proteomic profiling of GATA3 mutant metastatic hormone
receptor-positive breast cancer and impact on clinical outcomes.
Breast Cancer Res Treat. 2025 May 29. doi: 10.1007/s10549-025-07710.
PubMed
Abstract available
Exploring New Frontiers: Alternative Breast Cancer Treatments Through Glycocalyx
Research.
Breast J. 2025;2025:9952727.
PubMed
Abstract available
Efficacy of Presurgical Short-Term Endocrine Therapy During the Waiting Period
for Surgery in Postmenopausal Hormone Receptor-Positive Breast Cancer.
Breast J. 2025;2025:9976413.
PubMed
Abstract available
Implications of omitting sentinel lymph node biopsy on adjuvant decision making
for patients with small breast cancers.
Cancer. 2025;131:e35910.
PubMed
Abstract available
Therapeutic targeting of circTNK2 with nanoparticles restores tamoxifen
sensitivity and enhances NK cell-mediated immunity in ER-positive breast cancer.
Cancer Lett. 2025 May 24:217823. doi: 10.1016/j.canlet.2025.217823.
PubMed
Abstract available
CARM1-mediated MAP2K4 methylation potentiates the oncogenic functions of MAP2K4
and constitutes a targetable dependency in triple-negative breast cancer.
Cancer Res. 2025 May 29. doi: 10.1158/0008-5472.CAN-24-3476.
PubMed
Abstract available
A Radiomic and Clinical Data-Based Risk Model for Malignancy Prediction of Breast
BI-RADS 4A Microcalcifications.
Clin Breast Cancer. 2025;25:e461-e469.
PubMed
Abstract available
Is Immediate Breast Reconstruction an Option for Elderly Women? A Comparative
Study Between Elderly and Younger Population.
Clin Breast Cancer. 2025;25:e440-e449.
PubMed
Abstract available
Artificial Intelligence-Based Automatic Mitosis Scoring in Breast Cancer Improves
Inter-Observer Concordance and Efficiency.
Clin Breast Cancer. 2025 May 1:S1526-8209(25)00112.
PubMed
Abstract available
Trends in Incidence of Invasive Lobular Carcinoma of the Breast by Race: Patterns
by Age, Cancer Stage, and Socioeconomic Factors in the United States, 1992-2019.
Clin Breast Cancer. 2025;25:e394-e402.
PubMed
Abstract available
Computer-Aided Diagnosis of ER-positive, HER2-Negative Breast Cancer on Dynamic
Contrast-Enhanced MRI: Associations With Oncotype DX Recurrence Scores.
Clin Breast Cancer. 2025 Apr 29:S1526-8209(25)00105.
PubMed
Abstract available
Navigating Endocrine Sensitivity Assessment in Nonmetastatic Breast Cancer
Through Early On-Treatment Ki67 Understanding.
Clin Breast Cancer. 2025 Apr 30:S1526-8209(25)00111.
PubMed
Abstract available
The Mitochondrial Signature for Predicting Outcome of Early-Stage Breast Cancer
by Machine Learning.
Clin Breast Cancer. 2025 May 3:S1526-8209(25)00110.
PubMed
Abstract available
Clinical outcomes by histologic pattern of early-stage metaplastic breast cancer:
A single-institution retrospective study.
Clin Breast Cancer. 2025 May 3:S1526-8209(25)00113.
PubMed
Abstract available
Metabolomics Biomarkers for Breast Cancer: An updated perspective.
Clin Breast Cancer. 2025 May 8:S1526-8209(25)00118.
PubMed
Abstract available
Prospective multicentre study of patients with cutaneous metastases from breast
cancer treated with electrochemotherapy.
Clin Exp Metastasis. 2025;42:32.
PubMed
Abstract available
Assessing the diagnostic value of oncological biomarkers for identifying primary
malignancies in skeletal metastatic disease.
Eur J Surg Oncol. 2025;51:109688.
PubMed
Abstract available
Use of superparamagnetic iron oxide for sentinel lymph node detection following
neoadjuvant systemic therapy. A systematic review and meta-analysis.
Eur J Surg Oncol. 2025;51:109684.
PubMed
Abstract available
Invasive Pleomorphic Lobular Carcinoma of the breast: Clinicopathological
features, treatment patterns and outcomes.
Eur J Surg Oncol. 2025;51:109714.
PubMed
Abstract available
A qualitative study exploring the views of global healthcare professionals
towards de-escalation of axillary surgery in early breast cancer.
Eur J Surg Oncol. 2025;51:110079.
PubMed
Abstract available
More than density: validating a mammographic masking prediction model in Dutch
breast cancer screening.
Eur Radiol. 2025 May 29. doi: 10.1007/s00330-025-11687.
PubMed
Abstract available
EFHD1 promotes breast cancer progression through estrogen signaling.
Exp Cell Res. 2025 May 27:114620. doi: 10.1016/j.yexcr.2025.114620.
PubMed
Abstract available
Molecular targets and therapies associated with poor prognosis of triple?negative
breast cancer (Review).
Int J Oncol. 2025;66:52.
PubMed
Abstract available
Relationship of Immediate Breast Reconstruction and the Development of Lymphedema
in Breast Cancer Patients with Radiotherapy.
Int J Radiat Oncol Biol Phys. 2025 May 25:S0360-3016(25)00531.
PubMed
Abstract available
Inhibitory effects of beta-galactoside alpha2,6-sialyltransferase 1 on the Hippo pathway
in breast cancer cells.
J Biol Chem. 2025 May 21:110266. doi: 10.1016/j.jbc.2025.110266.
PubMed
Abstract available
The transcriptional regulator Sin3a activates CD44 and promotes collective
luminal breast cancer cell migration.
J Biol Chem. 2025 May 21:110264. doi: 10.1016/j.jbc.2025.110264.
PubMed
Abstract available
Granzyme B PET Imaging Predicts Response to Immunotherapy in a Diet-Induced
Obesity Model of Breast Cancer.
J Nucl Med. 2025 May 29:jnumed.124.268938. doi: 10.2967/jnumed.124.268938.
PubMed
Abstract available
Immediate Breast Reconstruction for Inflammatory Breast Carcinoma: A Scoping
Review.
J Surg Oncol. 2025;131:775-781.
PubMed
Abstract available
Breast cancer screening at a crossroads: supplemental imaging for dense breasts.
Lancet. 2025 May 21:S0140-6736(25)00803-7. doi: 10.1016/S0140-6736(25)00803.
PubMed
Comparison of supplemental breast cancer imaging techniques-interim results from
the BRAID randomised controlled trial.
Lancet. 2025 May 21:S0140-6736(25)00582-3. doi: 10.1016/S0140-6736(25)00582.
PubMed
Abstract available
Frank Invasion in Tall Cell Carcinoma With Reversed Polarity of the Breast:
Report of Two Cases.
Mod Pathol. 2025;38:100714.
PubMed
Abstract available
Classification of Fibroepithelial Lesions of the Breast in Core Needle Biopsy
With Implications for Further Management.
Mod Pathol. 2025;38:100734.
PubMed
Abstract available
HER2 testing: evolution and update for a companion diagnostic assay.
Nat Rev Clin Oncol. 2025;22:408-423.
PubMed
Abstract available
Treatment patterns and clinical outcomes of patients with HER2-positive T1micN0
breast cancer: a single-center analysis.
NPJ Breast Cancer. 2025;11:47.
PubMed
Abstract available
Clinicopathological and molecular characterization of inflammatory breast cancer,
the prospective INFLAME registry study.
NPJ Breast Cancer. 2025;11:48.
PubMed
Abstract available
[Retracted] Breast cancer cells are arrested at different phases of the cell
cycle following the re?expression of ARHI.
Oncol Rep. 2025;54:83.
PubMed
Abstract available
Integrated mathematical and experimental modeling uncovers enhanced EMT
plasticity upon loss of the DLC1 tumor suppressor.
PLoS Comput Biol. 2025;21:e1013076.
PubMed
Abstract available
Improving cancer detection through computer-aided diagnosis: A comprehensive
analysis of nonlinear and texture features in breast thermograms.
PLoS One. 2025;20:e0322934.
PubMed
Abstract available
Factors influencing clinical breast cancer screening: A cross-sectional study
among Islamic women in Kumasi Metropolis of Ghana.
PLoS One. 2025;20:e0320726.
PubMed
Abstract available
Radiological findings of adenoid cystic carcinoma of the breast.
Radiologia (Engl Ed). 2025;67:378-383.
PubMed
Abstract available
Impact of Background Parenchymal Enhancement on Diagnostic Performance of Breast
MRI: A Systematic Review and Meta-Analysis.
Radiology. 2025;315:e241919.
PubMed
Abstract available
The radiosensitizing effect of Caffeic Acid Phenethyl Ester in breast cancer is
dependent on p53 status.
Radiother Oncol. 2025;209:110945.
PubMed
Abstract available
Thank you for your interest in scientific medicine.